Vega-Garcia, N., Perez-Jaume, S., Esperanza-Cebollada, E., Vicente-Garces, C., Torrebadell, M., Jimenez-Velasco, A., . . . Camos, M. (2021). Measurable Residual Disease Assessed by Flow-Cytometry Is a Stable Prognostic Factor for Pediatric T-Cell Acute Lymphoblastic Leukemia in Consecutive SEHOP Protocols Whereas the Impact of Oncogenetics Depends on Treatment.
Citación estilo ChicagoVega-Garcia, N., et al. Measurable Residual Disease Assessed By Flow-Cytometry Is a Stable Prognostic Factor for Pediatric T-Cell Acute Lymphoblastic Leukemia in Consecutive SEHOP Protocols Whereas the Impact of Oncogenetics Depends On Treatment. 2021.
Cita MLAVega-Garcia, N., et al. Measurable Residual Disease Assessed By Flow-Cytometry Is a Stable Prognostic Factor for Pediatric T-Cell Acute Lymphoblastic Leukemia in Consecutive SEHOP Protocols Whereas the Impact of Oncogenetics Depends On Treatment. 2021.